Picture of OptiNose logo

OPTN — OptiNose News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

OptiNose Inc expected to post a loss of 27  cents a share - Earnings Preview

* OptiNose Inc  OPTN.OQ   OPTN.O  is expected to show a rise
in
quarterly revenue when it reports  results on May 12. 
    * The Yardley Pennsylvania-based  company is expected to
report  a
39.7% increase in revenue to $16.708 million from $11.96 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for OptiNose Inc is for
a
loss of 27 cents per share. For the same quarter last year, the
company reported a loss of 49 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for OptiNose
Inc is
$8​, above​ its last closing price of $1.96. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.24       -0.26      -0.23     Beat    11.5
 Sep. 30 2021  -0.38       -0.36      -0.32     Beat    10.6
 Jun. 30 2021  -0.40       -0.41      -0.44     Missed  -6.3​
 Mar. 31 2021  -0.53       -0.53      -0.49     Beat    7.5
 ​​Dec.        -0.46       -0.46      -0.46     Met     0.4
 31 2020                                                
 Sep. 30 2020  -0.51       -0.52      -0.43     Beat    17.8​
 Jun. 30 2020  -0.55       -0.56      -0.56     Met     0
 Mar. 31 2020  -0.66       -0.65      -0.63     Beat    3.8
 This summary was machine generated May 10 at 16:44 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on OptiNose

See all news